Caspian: Phase 3 study of first-line durvalumab ± tremelimumab + platinum-based chemotherapy vs chemotherapy alone in ED-SCLC

Category Primary study
JournalJournal of Thoracic Oncology
Year 2017
This article has no abstract
Epistemonikos ID: 57242f48467b1f3207a0e7535ca495da50afd892
First added on: Feb 08, 2025